Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.36B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$353M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$334M |
| 4 |
JPMorgan Chase
JPM
|
+$251M |
| 5 |
Amazon
AMZN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$713M |
| 2 |
Invesco WilderHill Clean Energy ETF
PBW
|
+$508M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$474M |
| 4 |
Tesla
TSLA
|
+$460M |
| 5 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$363M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.39% |
| 2 | Financials | 8.32% |
| 3 | Consumer Discretionary | 6.71% |
| 4 | Healthcare | 6.14% |
| 5 | Communication Services | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
ALX Oncology
ALXO
$262M
| $4.03M | ﹤0.01% |
54,690
+51,499
| +1,614% | +$4.05M |
|
1927
Syndax Pharmaceuticals
SNDX
$1.7B
| $4.03M | ﹤0.01% |
180,294
+173,310
| +2,482% | +$3.92M |
|
1928
Pan American Silver
PAAS
$17.9B
| $4.03M | ﹤0.01% |
134,193
-51,688
| -28% | -$1.68M |
|
1929
Armstrong World Industries
AWI
$7.37B
| $4.02M | ﹤0.01% |
44,643
+734
| +2% | +$62.3K |
|
1930
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$18.9B
| $4.02M | ﹤0.01% |
18,732
+3,701
| +25% | +$803K |
|
|
MANT
1931
DELISTED
Mantech International Corp
MANT
| $4.02M | ﹤0.01% |
46,224
-8,408
| -15% | -$733K |
|
1932
Planet Fitness
PLNT
$4.45B
| $4.01M | ﹤0.01% |
51,928
+39,095
| +305% | +$3.1M |
|
1933
Heron Therapeutics
HRTX
$93.4M
| $4.01M | ﹤0.01% |
247,239
+226,115
| +1,070% | +$4.03M |
|
|
NATI
1934
DELISTED
National Instruments Corp
NATI
| $4M | ﹤0.01% |
92,543
+16,990
| +22% | +$747K |
|
|
SRNE
1935
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $4M | ﹤0.01% |
483,066
+393,315
| +438% | +$4.15M |
|
1936
PUT
Avis
CAR
$5.47B
| $3.99M | ﹤0.01% |
55,000
-983,100
| -95% | -$50.8M |
|
1937
Denali Therapeutics
DNLI
$3.79B
| $3.98M | ﹤0.01% |
69,774
+52,179
| +297% | +$3.49M |
|
1938
Varonis Systems
VRNS
$4.67B
| $3.98M | ﹤0.01% |
77,576
-11,740
| -13% | -$696K |
|
1939
Brighthouse Financial
BHF
$3.61B
| $3.98M | ﹤0.01% |
89,861
-13,824
| -13% | -$568K |
|
|
HZNP
1940
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $3.98M | ﹤0.01% |
43,200
+33,500
| +345% | +$2.83M |
|
1941
PUT
VeriSign
VRSN
$26.3B
| $3.98M | ﹤0.01% |
20,000
| – | – |
|
1942
Sociedad Química y Minera de Chile
SQM
$19.3B
| $3.97M | ﹤0.01% |
74,899
-251,087
| -77% | -$13.8M |
|
|
DMTK
1943
DELISTED
DermTech, Inc. Common Stock
DMTK
| $3.97M | ﹤0.01% |
78,215
+76,655
| +4,914% | +$4.01M |
|
|
TPTX
1944
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $3.97M | ﹤0.01% |
41,919
+15,390
| +58% | +$1.83M |
|
1945
Hanover Insurance
THG
$8.13B
| $3.96M | ﹤0.01% |
30,587
+6,252
| +26% | +$754K |
|
1946
Fabrinet
FN
$14.9B
| $3.96M | ﹤0.01% |
43,746
+2,833
| +7% | +$245K |
|
1947
Nexstar Media Group
NXST
$6.01B
| $3.96M | ﹤0.01% |
28,168
+2,250
| +9% | +$294K |
|
1948
Valley National Bancorp
VLY
$7.9B
| $3.95M | ﹤0.01% |
287,270
+178,603
| +164% | +$2.15M |
|
|
VBIV
1949
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $3.94M | ﹤0.01% |
42,191
+40,637
| +2,615% | +$4.12M |
|
1950
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.84B
| $3.93M | ﹤0.01% |
24,497
+798
| +3% | +$137K |
|
Similar funds
Citigroup's Q1 2021 Portfolio in Review
As of Q1 2021, Citigroup held 7,934 positions worth $155B, down 8.7% from $169B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup withdrew a net $23.7B in Q1 2021, closing 1,718 positions and reducing 2,980 holdings. Its most notable exit was PARSLEY ENERGY INC, an estimated $102M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in ProShares UltraPro Short QQQ worth $176M.
- Citigroup's largest Q1 2021 buy was ProShares UltraPro Short QQQ: 107,444 shares worth $176M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $1.36B increase.
- Citigroup's biggest Q1 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $713M.
- Citigroup fully exited PARSLEY ENERGY INC in Q1 2021, selling an estimated $102M.
- Citigroup's ten largest holdings make up 21% of its $155B portfolio in Q1 2021.
- Citigroup opened 527 new positions and closed 1,718 in Q1 2021.
- Citigroup's portfolio value fell 8.7% quarter-over-quarter to $155B.
Based on Citigroup's 13F filing for Q1 2021, filed 13 May 2021.